Cargando…
DPP-4 inhibitors and severe course of illness in patients with COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816885/ https://www.ncbi.nlm.nih.gov/pubmed/33518293 http://dx.doi.org/10.1016/j.therap.2021.01.051 |
| _version_ | 1783638527628541952 |
|---|---|
| author | Bouhanick, Béatrice Cracowski, Jean-Luc Faillie, Jean-Luc |
| author_facet | Bouhanick, Béatrice Cracowski, Jean-Luc Faillie, Jean-Luc |
| author_sort | Bouhanick, Béatrice |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7816885 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78168852021-01-21 DPP-4 inhibitors and severe course of illness in patients with COVID-19 Bouhanick, Béatrice Cracowski, Jean-Luc Faillie, Jean-Luc Therapie Editorial Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2021 2021-01-18 /pmc/articles/PMC7816885/ /pubmed/33518293 http://dx.doi.org/10.1016/j.therap.2021.01.051 Text en © 2021 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial Bouhanick, Béatrice Cracowski, Jean-Luc Faillie, Jean-Luc DPP-4 inhibitors and severe course of illness in patients with COVID-19 |
| title | DPP-4 inhibitors and severe course of illness in patients with COVID-19 |
| title_full | DPP-4 inhibitors and severe course of illness in patients with COVID-19 |
| title_fullStr | DPP-4 inhibitors and severe course of illness in patients with COVID-19 |
| title_full_unstemmed | DPP-4 inhibitors and severe course of illness in patients with COVID-19 |
| title_short | DPP-4 inhibitors and severe course of illness in patients with COVID-19 |
| title_sort | dpp-4 inhibitors and severe course of illness in patients with covid-19 |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816885/ https://www.ncbi.nlm.nih.gov/pubmed/33518293 http://dx.doi.org/10.1016/j.therap.2021.01.051 |
| work_keys_str_mv | AT bouhanickbeatrice dpp4inhibitorsandseverecourseofillnessinpatientswithcovid19 AT cracowskijeanluc dpp4inhibitorsandseverecourseofillnessinpatientswithcovid19 AT failliejeanluc dpp4inhibitorsandseverecourseofillnessinpatientswithcovid19 |